U.S. Government Revamps Economic Strategy: The New Era of Dealmaking
Published on: Oct. 2, 2025, 6:50 p.m. | Source: Devdiscourse
The Trump administration is actively forming deals with pharmaceutical companies and over 30 other industries to ensure economic and national security. This strategic shift involves offering tariff relief and financial incentives, aiming for political gains before the 2026 midterm elections. A significant role is played by the International Development Finance Corporation, proposing a $250 billion funding increase to stabilize critical sectors. Critics argue this state-centric approach contradicts free-market principles.
